Companies see a commercial opportunity in creating new ways to administer drugs to patients in space.

Last week, the Iraqi cabinet approved plans to accelerate crude exports through the Kurdistan-Turkey pipeline network.

The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to bolster pipelines.

China's economy has shown signs of faltering following a strong first-quarter.

Chinese companies ramp up humanoid robot development and production, often with global aims.

Asia's technology stocks largely rebounded on Tuesday as investors returned to artificial intelligence-linked names, tracking Wall Street's gains.

Perplexity CEO Aravind Srinivas' comments come after AI giant Anthropic confidentially filed to go public.

CNBC's Jim Cramer said that he's becoming more cautious on stocks after several pillars of his bullish outlook have come under pressure.

Apple's artificial intelligence strategy took center stage at its Worldwide Developers Conference in Cupertino, Calif.

OpenAI's confidential filing lands days before SpaceX is set to go public and a week after Anthropic announced its confidential disclosure with the SEC.

Amazon joins the laundry list of partnerships Corning has secured in 2026, which includes Meta Platforms and Nvidia.

Sen. Elizabeth Warren said Nvidias CEO should answer questions publicly as lawmakers scrutinize AI chip sales to China and export controls.

Apple delivered on what Wall Street was expecting: a complete artificial intelligence overhaul.

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

Instead of selling AI tools to companies, venture firms are buying legacy companies outright and rebuilding them around AI from the inside.

Despite the overall bearish sentiment on the cohort, traders put a few bullish bets on potential semiconductor winners.

Airline CEOs complained that engine makers aren't making enough of their engines or that they're reliable enough.

Even used-car buyers may need a six-figure income to follow this popular car-buying rule.

"I think the majority view is that Lilly is pulling away, kind of Secretariat-like," Jim Cramer said Monday.

Chip stocks are bounding back Monday, but the rebound doesn't mean tech investors are in the clear, according to Mike Khouw.

Two weeks ago traders saw a 60% chance that the Strait of Hormuz would open before August. Now traders see a higher chance that it will open before 2027.

While the central bank's monthly survey showed the inflation outlook mostly unchanged, the general perception of conditions deteriorated.

Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.

The U.S. will lean on the same playbook it did starting in the late 1950s, part of which involves releasing sterile insects to suppress the pest's population.

The S&P 500 and Nasdaq were up as chipmakers rebounded after Friday's brutal selloff.